4.6 Article

Safety and efficacy of bronchial thermoplasty in Australia 5 years post-procedure

期刊

RESPIROLOGY
卷 -, 期 -, 页码 -

出版社

WILEY
DOI: 10.1111/resp.14568

关键词

asthma; bronchial thermoplasty; bronchoscopy and interventional techniques; BT; cohort study; radiological bronchiectasis

向作者/读者索取更多资源

In a cohort of severe asthmatics in the era of biological therapy, the safety and efficacy of bronchial thermoplasty (BT) was evaluated 5 years post-treatment. The results showed sustained improvement in symptoms control and reduced steroid requirement, but no change in spirometry. Mild localized radiological bronchiectasis was identified in some patients without clinical features.
Background and Objective: Outside clinical trials, there is limited long-term data following bronchial thermoplasty (BT). In a cohort of real-world severe asthmatics in an era of biological therapy, we sought to evaluate the safety and efficacy of BT 5 years post-treatment. Methods: Every patient treated with BT at two Australian tertiary centres were recalled at 5 years, and evaluated by interview and record review, Asthma Control Questionnaire (ACQ), spirometry and high-resolution CT Chest. CT scans were interpreted using the modified Reiff and BRICS CT scoring systems for bronchiectasis. Results: Fifty-one patients were evaluated. At baseline, this cohort had a mean age of 59.0 +/- 11.8 years, mean ACQ of 3.0 +/- 1.0, mean FEV1 of 55.5 +/- 18.8% predicted, and 53% were receiving maintenance oral steroids in addition to triple inhaler therapy. At 5 years, there was a sustained improvement in ACQ scores to 1.8 +/- 1.0 (p < 0.001). Steroid requiring exacerbation frequency was reduced from 3.8 +/- 3.6 to 1.0 +/- 1.6 exacerbations per annum (p < 0.001). 44% of patients had been weaned off oral steroids. No change in spirometry was observed. CT scanning identified minor degrees of localized radiological bronchiectasis in 23/47 patients with the modified Reiff score increasing from 0.6 +/- 2.6 at baseline to 1.3 +/- 2.5 (p < 0.001). However, no patients exhibited clinical features of bronchiectasis, such as recurrent bacterial infection. Conclusion: Sustained clinical benefit from BT at 5 years was demonstrated in this cohort of very severe asthmatics. Mild, localized radiological bronchiectasis was identified in a portion of patients without clinical features of bronchiectasis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据